RNA interference as an anticancer therapy: a patent perspective.

RNA interference as an anticancer therapy: a patent perspective.

Item
http://www.wikidata.org/entity/Q37481329
PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles.Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.Epstein-Barr virus: novel patented therapeutics.Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.Delivery of RNAi therapeutics: work in progress.Reversal of multidrug resistance by magnetic chitosan-Fe₃O₄ nanoparticle-encapsulated MDR₁ siRNA in glioblastoma cell line.Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells.
P2860

RNA interference as an anticancer therapy: a patent perspective.

Item
http://www.wikidata.org/entity/Q37481329
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RNA interference as an anticancer therapy: a patent perspective.
@en
RNA interference as an anticancer therapy: a patent perspective.
@nl
type
label
RNA interference as an anticancer therapy: a patent perspective.
@en
RNA interference as an anticancer therapy: a patent perspective.
@nl
prefLabel
RNA interference as an anticancer therapy: a patent perspective.
@en
RNA interference as an anticancer therapy: a patent perspective.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
RNA interference as an anticancer therapy: a patent perspective.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698